%0 Journal Article %T PD-1/PD-L1抑制剂在妇科肿瘤中的研究进展
Application of PD-1/PD-L1 Inhibitors in Gynecological Tumors %A 陈学维 %A 刘云聪 %A 朱国庆 %J World Journal of Cancer Research %P 48-54 %@ 2164-9057 %D 2024 %I Hans Publishing %R 10.12677/WJCR.2024.141008 %X 现今世界及中国的妇科恶性肿瘤呈逐年渐升趋势,已严重危及妇女们的身体健康。即使现有手术、化疗、放疗、靶向药物、介入等相结合的综合治疗方法可以延缓肿瘤的进展,提高总生存率(OS),也仍有恶性肿瘤经治疗后,肿瘤进展呈转移性、复发性、耐药性等概率升高的风险。目前,免疫治疗的兴起与发展,在许多实质肿瘤领域中日益成为临床研究中的热点,也在妇科肿瘤方面已步入尝试性临床研究应用,其中程序性死亡受体-1 (PD-1)及其配体(PD-L1)的抗体为例的免疫抑制剂,在卵巢癌(Ovarian Cancer, OC)、宫颈癌(Cervical Cancer, CC)、子宫内膜癌(Endometrial Cancer, EC)等妇科恶性肿瘤的相关临床试验中证实,PD-1/PD-L1抑制剂具有一定的抗肿瘤疗效。本文就PD-1/PD-L1抑制剂在妇科恶性肿瘤中的研究进展作一简要综述。
Nowadays, gynecological malignant tumors in the world and China are on the rise year by year, which has seriously endangered women’s health. Even if the existing comprehensive treatment methods, such as surgery, chemotherapy, radiotherapy, targeted drugs and intervention, can delay the progress of tumor and improve the overall survival rate (OS), there is still the risk that the probability of metastasis, recurrence and drug resistance of malignant tumor will increase after treatment. At present, the rise and development of immunotherapy has increasingly become a hot spot in clinical research in many solid tumor fields, and it has also entered a tentative clinical research application in gynecological tumors. Among them, antibodies against programmed death receptor-1 (PD-1) and its ligand (PD-L1) are immune suppressants, which are used in ovarian cancer (OC), cervical cancer (CC), endometrial cancer (EC) and other gynecological malignant tumors, and it has been confirmed that PD-1/PD-L1 inhibitors have a certain anti-tumor effect. In this paper, the research progress of PD-1/PD-L1 inhibitors in gynecological malignant tumors is briefly re-viewed. %K 程序性死亡受体-1 (PD-1),程序性死亡配体体(PD-L1),免疫治疗,卵巢癌,宫颈癌,子宫内膜癌,外阴癌
Programmed Death Receptor-1 (PD-1) %K Programmed Death Ligand (PD-L1) %K Immunotherapy %K Ovarian Cancer %K Cervical Cancer %K Endometrial Cancer %K Vulvar Cancer %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=79886